Development of gene silencing pyrrole-imidazole polyamide targeting the TGF-β1 promoter for treatment of progressive renal diseases

Journal of the American Society of Nephrology

Volumn 17, Issue 2, 2006, Pages 422-432

  Matsuda, Hiroyuki ^a   Fukuda, Noboru ^a,d   Ueno, Takahiro ^a   Tahira, Yoshiko ^a   Ayame, Hirohito ^b   Zhang, Wen ^b   Bando, Toshikazu ^b   Sugiyama, Hiroshi ^b   Saito, Satoshi ^a   Matsumoto, Koichi ^a   Mugishima, Hideo ^a   Serie, Kazuo ^c  

^a NIHON UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c Gentier Biosystems Incorporation   (Japan)

^d NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMIDAZOLE DERIVATIVE; POLYAMIDE; PYRROLE DERIVATIVE; PYRROLE IMIDAZOLE POLYAMIDE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; DNA BINDING; GENE ACTIVATION; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; KIDNEY DISEASE; KIDNEY INJURY; MALE; MESANGIUM CELL; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; RAT;

EID: 33645457692     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005060650     Document Type: Article

References (40)

1. Dervan PB: Molecular recognition of DNA by small molecules. Bioorg Med Chem 9: 2215-2235, 2001
2. Trauger JW, Baird EE, Dervan PB: Recognition of DNA by designed ligands at subnanomolar concentrations. Nature 382: 559-561, 1996
3. White S, Baird EE, Dervan PB: On the pairing rules for recognition in the minor groove of DNA by pyrrole-imidazole polyamides. Chem Biol 4: 569-578, 1997
4. Fujimoto K, Iida H, Kawakami M, Bando T, Tao ZF, Sugiyama H: Sequence-specific protection of plasmid DNA from restriction endonuclease hydrolysis by pyrrole-imidazole-cyclopropapyrroloindole conjugates. Nucleic Acids Res 30: 3748-3753, 2002
5. Murty MS, Sugiyama H: Biology of N-methylpyrrole-N-methylimidazole hairpin polyamide. Biol Pharm Bull 27: 468-474, 2004
6. Nguyen-Hackley DH, Ramm E, Taylor CM, Joung JK, Dervan PB, Pabo CO: Allosteric inhibition of zinc-finger binding in the major groove of DNA by minor-groove binding ligands. Biochemistry 43: 3880-3890, 2004
7. Dickinson LA, Gulizia RJ, Trauger JW, Baird EE, Mosier DE, Gottesfeld JM, Dervan PB: Inhibition of RNA polymerase II transcription in human cells by synthetic DNA-binding ligands. Proc Natl Acad Sci U S A 95: 12890-12895, 1998
8. Gilbert RE, Wilkinson-Berka JL, Johnson DW, Cox A, Soulis T, Wu LL, Kelly DJ, Jerums G, Pollock CA, Cooper ME: Renal expression of transforming growth factor-beta inducible gene-h3 (beta Ig-h3) in normal and diabetic rats. Kidney Int 54: 1052-1062, 1998
9. Yamamoto T, Noble NA, Cohen AH, Nast CC, Hishida A, Gold LI, Border WA: Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int 49: 461-469, 1996
10. Iwano M, Akai Y, Fujii Y, Dohi Y, Matsumura N, Dohi K: Intraglomerular expression of transforming growth factor-beta 1 (TGF-beta1) mRNA in patients with glomerulonephritis: Quantitative analysis by competitive polymerase chain reaction. Clin Exp Immunol 97: 309-314, 1994
11. Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B: Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 105: 1039-1045, 1987
12. Chen JK, Hoshi H, McKeehan WL: Transforming growth factor type beta specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells. Proc Natl Acad Sci U S A 84: 5287-5291, 1987
13. Kasuga H, Ito Y, Sakamoto S, Kawachi H, Shimizu F, Yuzawa Y, Matsuo S: Effects of anti-TGF-beta type II receptor antibody on experimental glomerulonephritis. Kidney Int 60: 1745-1755, 2001
14. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A 90: 1814-1818, 1993
15. Klahr S, Morrissey J: Obstructive nephropathy and renal fibrosis: The role of bone morphogenic protein-7 and hepatocyte growth factor. Kidney Int Suppl 87: S105-S112, 2003
16. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R: BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9: 964-968, 2003
17. Tamaki K, Okuda S, Nakayama M, Yanagida T, Fujishima M: Transforming growth factor-beta1 in hypertensive renal injury in Dahl salt-sensitive rats. J Am Soc Nephrol 7: 2578-2589, 1996
18. Tahira Y, Fukuda N, Endo M, Suzuki R, Ikeda Y, Takagi H, Matsumoto K, Kanmatsuse K: Transforming growth factor-beta expression in cardiovascular organs in stroke-prone spontaneously hypertensive rats with the development of hypertension. Hypertens Res 25: 911-918, 2002
19. Gore-Hyer E, Shegogue D, Markiewicz M, Lo S, Hazen-Martin D, Greene EL, Grotendorst G, Trojanowska M: TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells. Am J Physiol Renal Physiol 283: F707-F716, 2002
20. Matsumoto K, Hatano M: Production of interleukin 1 in glomerular cell cultures from rats with nephrotoxic serum nephritis. Clin Exp Immunol 75: 123-128, 1989
21. Yang Y, Mumy M, Romeo D, Wakefield LM: Identification of the start sites for the 1.9- and 1.4-kb rat transforming growth factor-beta1 transcripts and their effect on translational efficiency. Gene 219: 81-89, 1998
22. Bando T, Narita A, Saito I, Sugiyama H: Molecular design of a pyrrole-imidazole hairpin polyamide for effective DNA alkylation. Chemistry 8: 4781-4790, 2002
23. Magin-Lachmann C, Kotzamanis G, D'Aiuto L, Wagner E, Huxley C: Retrofitting BACs with G418 resistance, luciferase, and oriP and EBNA-1-New vectors for in vitro and in vivo delivery. BMC Biotechnol 3: 1-12, 2003
24. Harger JW, Dinman JD: An in vivo dual-luciferase assay system for studying translational recoding in the yeast Saccharomyces cerevisiae. RNA 9: 1019-1024, 2003
25. Wolf G, Ziyadeh FN: Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 56: 393-405, 1999
26. Ying WZ, Sanders PW: Dietary salt modulates renal production of transforming growth factor-beta in rats. Am J Physiol 274: F635-F641, 1998
27. Romeo D, Allison RS, Kondaiah P, Wakefield LM: Recharacterization of the start sites for the major human transforming growth factor-beta 1 mRNA. Gene 189: 289-295, 1997
28. Geiser AG, Kim SJ, Roberts AB, Sporn MB: Characterization of the mouse transforming growth factor-beta 1 promoter and activation by the Ha-ras oncogene. Mol Cell Biol 11: 84-92, 1991
29. Pennacchio LA, Rubin EM: Genomic strategies to identify mammalian regulatory sequences. Nat Rev Genet 2: 100-109, 2001
30. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV, Ignatieva EV, Ananko EA, Podkolodnaya OA, Kolpakov FA, Podkolodny NL, Kolchanov NA: Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 26: 362-367, 1998
31. Oyoshi T, Kawakami W, Narita A, Bando T, Sugiyama H: Inhibition of transcription at a coding sequence by alkylating polyamide. J Am Chem Soc 125: 4752-4754, 2003
32. Shinohara K, Narita A, Oyoshi T, Bando T, Teraoka H, Sugiyama H: Sequence-specific gene silencing in mammalian cells by alkylating pyrrole-imidazole polyamides. J Am Chem Soc 126: 5113-5118, 2004
33. Pertovaara L, Sistonen L, Bos TJ, Vogt PK, Keski-Oja J, Alitalo K: Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation. Mol Cell Biol 9: 1255-1262, 1989
34. Kim SJ, Denhez F, Kim KY, Holt JT, Sporn MB, Roberts AB: Activation of the second promoter of the transforming growth factor-beta 1 gene by transforming growth factor-beta 1 and phorbol ester occurs through the same target sequences. J Biol Chem 264: 19373-19378, 1989
35. Best TP, Edelson BS, Nickols NG, Dervan PB: Nuclear localization of pyrrole-imidazole polyamide-fluorescein conjugates in cell culture. Proc Natl Acad Sci U S A 100: 12063-12068, 2003
36. Belitsky JM, Leslie SJ, Arora PS, Beerman TA, Dervan PB: Cellular uptake of N-methylpyrrole/N-methylimidazole polyamide-dye conjugates. Bioorg Med Chem 10: 3313-3318, 2002
37. Gupta S, Clarkson MR, Duggan J, Brady HR: Connective tissue growth factor: Potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int 58: 1389-1399, 2000
38. Yokoi H, Sugawara A, Mukoyama M, Mori K, Makino H, Suganami T, Nagae T, Yahata K, Fujinaga Y, Tanaka I, Nakao K: Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: A potential target for preventing renal fibrosis. Am J Kidney Dis 38: 134-138, 2001
39. Sanders PW: Salt intake, endothelial cell signaling, and progression of kidney disease. Hypertension 43: 142-146, 2004
40. Dahly AJ, Hoagland KM, Flasch AK, Jha S, Ledbetter SR, Roman RJ: Antihypertensive effects of chronic anti-TGF-beta antibody therapy in Dahl S rats. Am J Physiol Regul Integr Comp Physiol 283: R757-R767, 2002